IndraLab

Statements


USP18 inhibits JAK1. 5 / 7
| 5

reach
"USP18 competes with JAK1 for IFNAR2 receptor binding, reducing JAK1 and STAT activation (15, 16)."

reach
"USP18 inhibits type I interferon signaling by preventing Janus-associated kinase 1 (JAK1) from binding to the type I interferon receptor."

reach
"One group has proposed that USP18 attenuates IFN alpha signaling regardless of the isopeptidase activity of the protein by competitively displacing Jak1 from its interaction with IFNAR2 XREF_BIBR."

reach
"USP18 has been shown to suppress the Jak-STAT pathway through specific binding to IFNAR2 and restricting the access of the Jak1 kinase to its docking site at the receptor ( Fig. 2 ) [52] ."

reach
"Postactivation silencing of IFNAR signaling is achieved quickly after IFN exposure and is mediated by at least two proteins that are ISGs themselves and therefore accumulate in response to IFN: Suppressor of cytokine signaling 1 (SOCS1) binds and inhibits TYK2, whereas USP18 (UBP43) occupies IFNAR2 and hence blocks JAK1 activation (83, 84)."